Chargement des cours...
Prévisions
Aucune donnée d'analyste n'est disponible pour cette entreprise.
Actualités Accéder au fil d'actualités
Zentek receives standing-offer contract from the Government of Canada for ZenGUARD air filters
Zentek has been awarded a standing-offer contract with the Government of Canada to supply HVAC filters, including the ZenGUARD Enhanced Air Filter, for federal sites in the National Capital Region. The contract runs from August 19, 2026, to August 18, 2027, with a maximum value of 348,666.84 CAD and pre-set prices for ministry call-ups. National Research Council of Canada tests showed about a fivefold improvement in aerosol filtration performance; a pilot project yielded 22% lower fan energy use versus conventional MERV-13 pleated filters. In May 2026 ZenGUARD was added to Innovative Solutions Canada’s “Pathway to Commercialization” procurement list, listing Zentek as a potential exclusive supplier for federal sites, without a minimum purchase guarantee. » Plus sur de.investing.com
Zentek files provisional patent application for electromagnetic shielding coating
Zentek has filed a provisional application with the US Patent Office for ZEN-EMI-01, a water-based shielding coating made from Albany graphite, ferrite particles and a conductive polymer. Internal tests showed that a thin layer predominantly attenuates microwaves in the 8–12 GHz band by absorption; these results have not been independently verified. The filing establishes a priority date and starts a twelve-month period for international filings; the development program includes third-party testing, formulation optimization, qualification tests and scale-up, so far without customer contracts. » Plus sur de.investing.com
Zentek hires IMPAQ Capital for investor relations in North America
Zentek has engaged IMPAQ Capital to manage communications with investment professionals in North America. The agreement begins immediately, initially runs for six months and automatically renews for three-month periods; IMPAQ will receive C$13,500 per month and no securities will be issued. The engagement is subject to approval by the TSX Venture Exchange; Zentek is currently trading with a market capitalization of $44.8m at $0.06 per share and remains unprofitable despite revenues of $1.68m in the last twelve months. » Plus sur de.investing.com
Dividendes historiques Dividendes
Tous les indicateurs de dividendes Tous les indicateursDonnées financières de l'entreprise
| (EUR) | juin 2026 | |
|---|---|---|
| Chiffre d'affaires | 0,00 | 100,00% |
| Bénéfice brut | −754,14k | 4.547,07% |
| Bénéfice net | −1,26M | 48,43% |
| EBITDA | −1,27M | 75,01% |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 60,87M€ |
Nombre d'actions | 126,62M |
Plus haut/bas sur 52 semaines | 1,06€ - 0,32€ |
| Dividendes | Non |
Bêta | 0,29 |
Ratio P/E | −8,22 |
Ratio PEG | 0,58 |
Ratio P/B | 3,52 |
Ratio P/S | 900,66 |
Profil de l'entreprise
Zentek Ltd. beschäftigt sich mit der Forschung und Entwicklung von Graphen und verwandten Nanomaterialien in Kanada. Das Unternehmen besitzt eine 100%ige Beteiligung am Albany-Graphitprojekt im Norden Ontarios, Kanada. Das Unternehmen entwickelt antimikrobielle Beschichtungen auf Graphenbasis sowie chirurgische Masken, HVAC-Filter und persönliche Schutzausrüstung. Es entwickelt auch die Synthese von Graphen, Graphenoxid und Graphen-Quantenpunkten für Anwendungen von Graphen. Das Unternehmen war früher als ZEN Graphene Solutions Ltd. bekannt und änderte im Oktober 2021 seinen Namen in Zentek Ltd. Zentek Ltd. wurde im Jahr 2008 gegründet und hat seinen Sitz in Thunder Bay, Kanada.
| Nom | Zentek Aktie |
| PDG | Mohammed Jiwan |
| Siège social | Guelph,
on Canada |
| Site web | |
| Secteur | Matériaux |
| Industrie | Produits chimiques |
| Introduction en bourse | 14/11/2016 |
| Employés | 10 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
NASDAQ | ZTEK |
Tsxv | ZEN.V |
Frankfurt | ZAY0.F |
Düsseldorf | ZAY0.DU |
München | ZAY0.MU |
Découvrir des actifs
Les actionnaires de Zentek Aktie investissent également dans les actifs suivants

